(Q40749244)

English

Antitumor activity of the selective epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) Iressa (ZD1839) in an EGFR-expressing multidrug-resistant cell line in vitro and in vivo

scientific article published on March 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Antitumor activity of the selective epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) Iressa (ZD1839) in an EGFR-expressing multidrug-resistant cell line in vitro and in vivo (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

multiple drug resistance

1 reference

based on heuristic

inferred from title

author name string

Ichiro Naruse

1

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Tohru Ohmori

2

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Yoko Ao

3

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Hisao Fukumoto

4

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Toshio Kuroki

5

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Masatomo Mori

6

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Nagahiro Saijo

7

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Kazuto Nishio

8

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

language of work or name

0 references

publication date

1 March 2002

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

98

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

310-315

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

The molecular genetics of cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10173

21 January 2018

Viral oncogenes

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10173

21 January 2018

A thousand and one protein kinases

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10173

21 January 2018

Signal transduction by receptors with tyrosine kinase activity

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10173

21 January 2018

Receptors for epidermal growth factor and other polypeptide mitogens

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10173

21 January 2018

Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10173

21 January 2018

Epidermal growth factor, oestrogen and progesterone receptor expression in primary ovarian cancer: correlation with clinical outcome and response to chemotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10173

21 January 2018

Epidermal growth factor receptors in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10173

21 January 2018

The relationship of quantitative epidermal growth factor receptor expression in non-small cell lung cancer to long term survival

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10173

21 January 2018

Studies leading to the identification of ZD1839 (IRESSA): an orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatment of cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10173

21 January 2018

The EGF receptor family as targets for cancer therapy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10173

21 January 2018

Clinical relevance of transmembrane drug efflux as a mechanism of multidrug resistance.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10173

21 January 2018

Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10173

21 January 2018

Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10173

21 January 2018

Establishment of a human leukemia subline resistant to the growth-inhibitory effect of 12-o-tetradecanoylphorbol 13-acetate (TPA) and showing non-P-glycoprotein-mediated multi-drug resistance

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10173

21 January 2018

Epidermal growth factor receptor is increased in multidrug-resistant Chinese hamster and mouse tumor cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10173

21 January 2018

Reversal of multidrug resistance by tyrosine-kinase inhibitors in a non-P-glycoprotein-mediated multidrug-resistant cell line

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10173

21 January 2018

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10173

21 January 2018

Increased epidermal growth factor receptor in an estrogen-responsive, adriamycin-resistant MCF-7 cell line

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10173

21 January 2018

Increased epidermal growth factor receptor in multidrug-resistant human neuroblastoma cells.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10173

21 January 2018

Regulation of multidrug resistance through the cAMP and EGF signalling pathways

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10173

21 January 2018

A multidrug-resistant MCF-7 human breast cancer cell line which exhibits cross-resistance to antiestrogens and hormone-independent tumor growth in vivo.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10173

21 January 2018

Characterization of a human small-cell lung cancer cell line resistant to a new water-soluble camptothecin derivative, DX-8951f

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10173

21 January 2018

Characterisation of a vindesine-resistant human small-cell lung cancer cell line

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10173

21 January 2018

Characterization of a taxol-resistant human small-cell lung cancer cell line

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10173

21 January 2018

ZD1839 ('Iressa') as an anticancer agent

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10173

21 January 2018

Requirement for intrinsic protein tyrosine kinase in the immediate and late actions of the EGF receptor

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10173

21 January 2018

Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10173

21 January 2018

Reversal of adriamycin resistance with chimeric anti-ganglioside GM2 antibody

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10173

21 January 2018

Identifiers

10.1002/IJC.10173

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40749244&oldid=2188461585"